|
Tabla 2: Signos, síntomas y diferencias clínicas entre grupos de edad. |
||||
|
Variable |
Menores de 12 años N = 111 n (%) |
12 años o mayores N = 81 n (%) |
Total N = 192 n |
p* |
|
Dengue severo |
5 (4.5) |
1 (1.2) |
6 |
0.372‡ |
|
Dengue sin signos de alarma |
65 (58.6) |
47 (58.0) |
112 |
— |
|
Dengue con signos de alarma |
41 (36.9) |
33 (40.7) |
74 |
— |
|
Síntomas generales |
||||
|
Fiebre |
100 (100.0) |
75 (92.6) |
186 |
0.004 |
|
Mialgias |
90 (81.1) |
69 (85.2) |
159 |
0.457 |
|
Artralgias |
85 (76.6) |
69 (85.2) |
154 |
0.139 |
|
Adinamia |
91 (82.0) |
66 (81.5) |
157 |
0.929 |
|
Astenia |
78 (70.3) |
54 (66.7) |
132 |
0.595 |
|
Cefalea |
89 (80.2) |
75 (92.6) |
164 |
0.016 |
|
Dolor retroorbitario |
44 (39.6) |
45 (55.6) |
89 |
0.029 |
|
Dolor de espalda baja |
8 (7.2) |
28 (34.6) |
36 |
0.000 |
|
Mareo |
35 (31.6) |
38 (46.9) |
73 |
0.030 |
|
Calosfríos |
58 (52.3) |
55 (67.9) |
113 |
0.030 |
|
Vómitos |
71 (64.0) |
44 (54.3) |
115 |
0.178 |
|
Dolor abdominal |
75 (67.0) |
52 (64.2) |
127 |
0.626 |
|
Diarrea |
39 (35.1) |
27 (33.3) |
66 |
0.795 |
|
Signos dermatológicos |
||||
|
Prurito |
62 (55.9) |
32 (39.5) |
94 |
0.025 |
|
Rash |
24 (21.6) |
8 (9.9) |
32 |
0.031 |
|
Descamación |
4 (3.6) |
2 (2.5) |
6 |
1.000 |
|
Hallazgos clínicos y hematológicos |
||||
|
Hematuria |
5 (4.5) |
14 (17.3) |
19 |
0.003 |
|
Hipotensión |
63 (56.8) |
16 (19.8) |
79 |
0.000 |
|
Taquipnea |
53 (47.7) |
56 (69.1) |
109 |
0.003 |
|
Bradicardia |
19 (17.1) |
14 (17.3) |
33 |
0.976 |
|
Trombocitopenia§ |
72 (64.9) |
51 (63.0) |
123 |
0.119 |
|
Hemoconcentración (> 10%)§ |
25 (22.5) |
25 (30.9) |
50 |
0.082 |
|
* χ2 de asociación. ‡ Prueba de Fisher. § Faltantes: 5. Valor en negrita indica la significancia estadística. Modificada de: Salazar FJE et al.26 |
||||